肝脏分子特征揭示非酒精性脂肪性肝炎的性别二态性
该研究基于910例肥胖患者队列的肝脏转录组,按严格组织学分层为「无NASH」与「NASH」,发现性别是数据异质性的主要因素,并鉴定了性别依赖的NASH差异表达基因与随机森林基因特征,可在独立队列中高精度识别NASH患者。
要点
- 性别是NASH肝脏转录组异质性的主要因素。
- NASH相关差异表达基因及生物学过程随性别不同。
- 随机森林基因特征可在独立队列中高精度识别NASH。
核心结论
- 大规模人肝转录组分析强调NASH具有性别二态性,并与纤维化相关。
- 研究呼吁将性别作为NASH进展及药物反应的主要决定因素纳入考量。
研究设计与样本
- 研究基于910例肥胖患者队列,按严格组织学特征分层为「无NASH」与「NASH」患者。
- 对肝脏转录组谱进行分析,采用bootstrapping与随机森林(RF)方法鉴定差异表达基因。
主要发现
- 性别被确定为该队列数据异质性的主要因素。
- 鉴定出随性别不同而参与不同生物学过程的可靠差异表达基因。
- RF计算的基因特征在独立队列中以高准确度识别NASH患者。
临床怎么用
- 解读NASH肝脏分子标志物与转录组特征时应考虑性别差异。
- 性别应作为NASH进展评估与药物反应分析的重要分层因素。
局限性
- 原文指出NASH队列有限且需肝活检金标准,可能解释已发表组学NASH特征重叠不佳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Nonalcoholic steatohepatitis (NASH) is considered as a pivotal stage in nonalcoholic fatty liver disease (NAFLD) progression, given that it paves the way for severe liver injuries such as fibrosis and cirrhosis. The etiology of human NASH is multifactorial, and identifying reliable molecular players and/or biomarkers has proven difficult. Together with the inappropriate consideration of risk factors revealed by epidemiological studies (altered glucose homeostasis, obesity, ethnicity, sex, etc.), the limited availability of representative NASH cohorts with associated liver biopsies, the gold standard for NASH diagnosis, probably explains the poor overlap between published "omics"-defined NASH signatures. APPROACH AND RESULTS: Here, we have explored transcriptomic profiles of livers starting from a 910-obese-patient cohort, which was further stratified based on stringent histological characterization, to define "NoNASH" and "NASH" patients. Sex was identified as the main factor for data heterogeneity in this cohort. Using powerful bootstrapping and random forest (RF) approaches, we identified reliably differentially expressed genes participating in distinct biological processes in NASH as a function of sex. RF-calculated gene signatures identified NASH patients in independent cohorts with high accuracy. CONCLUSIONS: This large-scale analysis of transcriptomic profiles from human livers emphasized the sexually dimorphic nature of NASH and its link with fibrosis, calling for the integration of sex as a major determinant of liver responses to NASH progression and responses to drugs.
引用
- Vandel J, Dubois-Chevalier J, Gheeraert C, et al. Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH). Hepatology. 2020. PMID: 32394476. doi:10.1002/hep.31312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。